Release Summary

Ironwood Pharmaceuticals begins a Phase IIa clinical study of investigational guanylate cyclase-C (GC-C) agonist, IW-9179, in symptomatic relief of patients with diabetic gastroparesis.

Ironwood Pharmaceuticals, Inc.